Genetic blood clot risk tied to 21% higher long COVID odds
New genetic evidence reveals why some people develop long COVID while others don'tβand it has to do with blood clots. Plus, researchers are mapping the brain changes behind persistent symptoms.
𧬠Genes predict long COVID risk through blood clotting pathways
Genetic analysis of 3,018 long COVID patients and 994,582 controls found that people with genetic variants increasing blood clot risk had 21% higher odds of developing long COVID
The association was independent of how severe their initial COVID infection was, suggesting blood clotting mechanisms drive long-term symptoms regardless of acute illness
Researchers identified protease-activated receptor 1 (PAR-1), a protein involved in blood clotting, as a potential molecular contributor to long COVID symptoms
Why it matters: This provides the first human genetic evidence that thromboembolism (blood clot formation) and long COVID share biological pathways, potentially explaining why some people develop persistent symptoms while others recover completely.
Key Findings
π§ Brain fog hits cognitive performance harder in long COVID than chemotherapy
Meta-analysis of 65 studies found people with long COVID brain fog scored significantly lower on cognitive tests compared to controls
Long COVID patients also reported 2.64 times higher fatigue levels and 1.48 times more depressive symptoms than those without brain fog
Montreal Cognitive Assessment was the most common test used, but researchers noted wide variation in how brain fog is measured across studies
π΄ Long COVID disrupts sleep for nearly 3 years after infection
Study of 2,406 Michigan adults found long COVID patients slept 0.35 hours less per night 1.5 years after infection
People with long COVID were 3.27 times more likely to sleep less than 6 hours nightly and 1.53 times more likely to experience moderate-to-severe sleep disturbance
Sleep problems persisted even 3 years post-infection, with long COVID patients nearly twice as likely to get inadequate sleep
π« COVID survivors develop unusual sleep apnea pattern
Study of 152 COVID survivors found 47.4% developed REM-predominant sleep apnea compared to just 17.8% of controls
People with this specific sleep apnea pattern were significantly more likely to report frequent fatigue (52.8% vs 35.7%)
COVID survivors actually had lower overall sleep apnea rates (50% vs 77.6%), but when they did develop it, it followed this unusual REM-heavy pattern
π¬ Ultrasound breaks down stubborn blood clots linked to long COVID
Low-frequency ultrasound at 150 kHz reduced amyloid microclot diameter by over 60% and eliminated more than 80% of large clots
These persistent microclots resist normal clot-dissolving enzymes and have been found in long COVID patients
Adding clot-dissolving drugs to ultrasound treatment provided only modest additional benefit, suggesting mechanical disruption is key
𧬠Genetic variant affects COVID severity through metabolism pathway
Patients with the C677T variant of the MTHFR gene who also had abnormal methionine metabolism levels experienced more severe COVID-19
One-carbon metabolism, a biochemical pathway critical for cellular function, was significantly disrupted in severe COVID patients
This genetic variant is relatively common and affects how the body processes certain vitamins and amino acids
π§ Brain scans reveal physical changes in long COVID patients
MRI scans of 47 participants showed altered brain tissue signals in long COVID patients compared to both recovered COVID patients and healthy controls
Brain tissue microstructure changes correlated with physical and cognitive function scores
Long COVID patients also had different brain chemical levels compared to people who recovered from COVID without lasting symptoms
Implications
These studies paint a clearer picture of long COVID as a multi-system disorder with measurable biological changesβfrom genetic blood clotting predisposition to altered brain structure and disrupted sleep patterns. The genetic findings particularly suggest that some people may be biologically predisposed to persistent symptoms, opening doors for personalized treatment approaches.
Studies in this issue
Primary sources used for this newsletter.
- Genetic Links Between Blood Clots and Long COVID in People of European Descentmain storyNature cardiovascular research2025-12-16PMID 41402665
- REM-related obstructive sleep apnea in adults with past COVID-19 infectionkey findingSleep medicine2025-12-18PMID 41411839
- Combined Enzyme and Ultrasound Treatment May Break Down Amyloid Microclotskey findingJournal of thrombosis and thrombolysis2025-12-17PMID 41405757
- Memory and thinking problems in long COVID and after chemotherapy: a review and combined analysiskey findingBMJ mental health2025-12-17PMID 41407484
- Long COVID and Sleep Health Nearly 3 Years After COVID-19 Infectionkey findingSleep2025-12-18PMID 41408718
- MTHFR gene type and related metabolism predict how severe COVID-19 may bekey findingProceedings of the National Academy of Sciences of the United States of America2025-12-18PMID 41410771
- Changes in brain tissue and chemical signals in people with long COVID and those recovered from COVID-19key findingBrain, behavior, & immunity - health2025-12-17PMID 41404601
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.